arrow
M

Maha Ayyoub

Institut national de la santé et de la recherche médicale
H指数:40
被引数:6,797

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Terminal T-cell exhaustion predicts tumor control independent of immunotherapy in ovarian cancer

T细胞耗竭终末阶段独立于免疫治疗预测卵巢癌肿瘤控制

2026-04-100
OAAI
The evolving role of Hospital Oncology Pharmacists (HOPs) in assessing therapeutic innovations and managing toxicities in cancer care

医院肿瘤药师(HOPs)在评估治疗创新和管理癌症护理毒性方面的演变角色

2025-12-010
PRE
TNF signature in advanced melanoma patients treated with immune checkpoint inhibitors: Results from the MELANFα clinical study

免疫检查点抑制剂治疗的晚期黑色素瘤患者的TNF特征: 来自melanf α 临床研究的结果

2025-03-010
OAAI
Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer
2023-11-223
OAAI
Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancers

人类癌症的单细胞转录组学揭示的 γ δ T和T CD8肿瘤浸润淋巴细胞的分阶段分化

2021-09-1811
OA
PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells
2021-01-2589
OA
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy
IMMUNITY
IF26.3
2020-10-01109
OAAI
Circulating CD14high CD16low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression
2020-06-0423
OAAI
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
Science
IF45.8
2020-01-010
OAAI
Predictors of responses to immune checkpoint blockade in advanced melanoma

晚期黑色素瘤对免疫检查点阻断反应的预测因子

2017-09-19188
OAAI
Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis
2016-05-0133
OAAI